The National Cancer Institute hosts a webinar series called Ethical and Regulatory Issues in Cancer Research (ENRICH). This speaker series fosters discussion about ethical and regulatory issues impacting cancer research. Our CEO/President, Ellen Matloff, was the keynote speaker in the latest webinar titled, “A Scalable Model for Returning Continually Updated Genetic Results to Consumers and…

Read More

Today’s podcast is a survival story meant to remind us that in the midst of cancer their is hope. In this conversation, Joan shares her story of early an onset Stage II breast cancer diagnosis at 27, genetic testing and a BRCA mutation at 42 and Stage IIIA ovarian cancer at age 47. Speaking now…

Read More

A major issue for female cancer previvors and survivors that have undergone an oophorectomy or hysterectomy is sex following surgery. And as you may expect, it’s an issue that patients and clinicians don’t always know how to talk about or address. This can leave some women to feel that there is no hope of ever regaining a satisfying…

Read More

Following Angelina Jolie Pitt’s disclosure earlier this week that she recently underwent a prophylactic bilateral salpingo-oophorectomy, we held an impromptu Tweet chat to discuss hereditary cancer and risk management. The BRCA community has certainly been lucky to have an advocate with a celebrity voice helping to spread awareness by sharing her personal story. But it’s just that – a personal story. Each member of a family…

Read More

Update: The American College of Obstetricians and Gynecologists (ACOG) recently published a committee opinion for women of population risk to develop ovarian cancer. ACOG recommends that average-risk women who are having gynecological surgery (such as removal of their uterus (hysterectomy) or having their tubes tied (tubal ligation) be counseled about the option of having their fallopian tubes removed (salpingectomy) at…

Read More